Imunon
Clinical trials sponsored by Imunon, explained in plain language.
-
New combo aims to wipe out hidden ovarian cancer after chemo
Disease control Recruiting nowThis study tests whether adding an experimental drug (IMNN-001) to standard chemotherapy and bevacizumab can better eliminate leftover cancer in people with advanced ovarian, fallopian tube, or peritoneal cancer. About 30 newly diagnosed participants will be randomly assigned to …
Phase: PHASE1, PHASE2 • Sponsor: Imunon • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New hope for ovarian cancer: experimental drug plus chemo enters phase 3 trial
Disease control Recruiting nowThis phase 3 trial tests whether adding the experimental drug IMNN-001 to standard chemotherapy helps people with advanced ovarian, fallopian tube, or primary peritoneal cancer live longer. About 500 newly diagnosed adults will receive either chemo alone or chemo plus IMNN-001, g…
Phase: PHASE3 • Sponsor: Imunon • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC